In reply [21]

Journal of Clinical Oncology

Volumn 23, Issue 16, 2005, Pages 3872-3873

  Devine, Steven ^a   Gazitt, Yair ^b   Calandra, Gary ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CHEMOKINE RECEPTOR CXCR4; GRANULOCYTE COLONY STIMULATING FACTOR; STROMAL CELL DERIVED FACTOR 1;

CELL MOTILITY; COMBINATION CHEMOTHERAPY; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMAN; LETTER; LEUKAPHERESIS; MONOTHERAPY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 33846943351     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.295     Document Type: Letter

References (2)

1. Devine SM, Flomenberg N, Vesole DH, et al: Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J Clin Oncol 22:1095-1102, 2004
2. Passas A, Fox M, Calandra G, et al: Successful mobilization of peripheral blood stem cells (PBSCs) with AMD3100 in patients failing to collect with hematopoietic growth factors (HGF) and/or chemotherapy. Proc Am Soc Clin Oncol 23:591, 2004 (abstr 6643)